Medpace Holdings, Inc. (MEDP)
599.47
+1.39
(+0.23%)
USD |
NASDAQ |
Oct 02, 16:00
599.50
+0.03
(+0.01%)
After-Hours: 20:00
Medpace Holdings Profit Margin (Quarterly) : 17.16% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.16% |
| March 31, 2026 | 17.53% |
| December 31, 2025 | 19.07% |
| September 30, 2025 | 16.84% |
| June 30, 2025 | 14.96% |
| March 31, 2025 | 20.52% |
| December 31, 2024 | 21.81% |
| September 30, 2024 | 18.08% |
| June 30, 2024 | 16.73% |
| March 31, 2024 | 20.07% |
| December 31, 2023 | 15.70% |
| September 30, 2023 | 14.32% |
| June 30, 2023 | 13.24% |
| March 31, 2023 | 16.78% |
| December 31, 2022 | 17.41% |
| September 30, 2022 | 17.19% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 18.52% |
| December 31, 2021 | 16.20% |
| September 30, 2021 | 16.38% |
| June 30, 2021 | 14.30% |
| March 31, 2021 | 16.60% |
| Date | Value |
|---|---|
| December 31, 2020 | 19.51% |
| September 30, 2020 | 17.94% |
| June 30, 2020 | 11.73% |
| March 31, 2020 | 12.51% |
| December 31, 2019 | 12.93% |
| September 30, 2019 | 11.06% |
| June 30, 2019 | 12.79% |
| March 31, 2019 | 9.54% |
| December 31, 2018 | 11.80% |
| September 30, 2018 | 10.73% |
| June 30, 2018 | 9.70% |
| March 31, 2018 | 8.89% |
| December 31, 2017 | 9.98% |
| September 30, 2017 | 8.87% |
| June 30, 2017 | 8.98% |
| March 31, 2017 | 7.91% |
| December 31, 2016 | -0.02% |
| September 30, 2016 | 4.67% |
| June 30, 2016 | 4.68% |
| March 31, 2016 | 3.46% |
| December 31, 2015 | -8.93% |
| September 30, 2015 | -0.14% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 5.90% |
| Charles River Laboratories International, Inc. | -0.08% |
| Avantor, Inc. | 2.25% |
| Champions Oncology, Inc. | -2.80% |
| Personalis, Inc. | -141.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 125.6% |
| Return on Assets | 25.90% |
| Return on Invested Capital | 91.76% |
| Gross Profit Margin (Quarterly) | 27.56% |
| Operating Margin (Quarterly) | 20.76% |
| Return on Net Operating Assets | 36.22% |